Engineered Neuronal Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Engineered neuronal cells are genetically, molecularly, or structurally modified neurons created for research, disease modeling, and therapeutic applications in neurodegeneration.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
- CRISPR/Cas9 modifications
- Viral vector transduction
- Site-specific recombination
- Synthetic biology
- Optogenetic constructs
- Chemogenetic tools
- Fluorescent reporters
- Biosensors
- Scaffold-based neurons
- 3D-printed neurons
- Organoid integration
- Microfluidic devices
- APP mutant neurons
- Presenilin mutants
- Tau transgenic neurons
- APOE variant neurons
- LRRK2 mutant neurons
- SNCA mutant neurons
- PINK1 deficient
- Parkin deficient
- SOD1 mutant neurons
- C9orf72 expanded
- TDP-43 mutant
- FUS mutant
- Embryonic stem cell derivatives
- iPSC-derived neurons
- Direct reprogramming
- Xenotransplantation
- Therapeutic gene delivery
- CRISPR correction
- RNA-based therapies
- Epigenetic modulation
- High-throughput platforms
- Patient-specific models
- Phenotypic screening
- Target validation
- Human genetic background
- Disease-specific mutations
- Authentic pathology
- Translational potential
- Isogenic lines
- Precise modifications
- Controlled expression
- Conditional systems
- Differentiation efficiency
- Maturation states
- Functional validation
- Consistency
- Aging effects
- Disease relevance
- Complexity
- Integration
The study of Engineered Neuronal Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kaye et al., Engineered neurons for disease modeling (2019)
- Chandran et al., iPSC disease modeling (2017)
- Sterneckert et al., CRISPR in neurons (2014)
- Devine et al., Engineered stem cells (2011)